AN05
Showing 1 - 25 of >10,000
Depression, Bipolar Trial in Aalborg (Lithium, Cariprazine)
Recruiting
- Depression, Bipolar
-
Aalborg, DenmarkAalborg University Hospital
Jun 19, 2023
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis Trial in Worldwide (AMB-05X)
Active, not recruiting
- Tenosynovial Giant Cell Tumor
- Pigmented Villonodular Synovitis
- AMB-05X
-
Columbus, Ohio
- +5 more
Oct 5, 2022
Schizophrenia and Related Disorders, MDD, Bipolar Depression Trial (Clozapine, Esketamine Nasal Product, Escitalopram)
Not yet recruiting
- Schizophrenia and Related Disorders
- +2 more
- Clozapine
- +11 more
- (no location specified)
Jan 12, 2023
Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)
Active, not recruiting
- Uveitis
- +2 more
- Sham Injector
- FAI Insert
-
Waltham, MassachusettsEyePoint Study Site
Dec 20, 2022
Breast Cancer, Psychological Distress Trial in Los Angeles (Improvisational comedy classes, Waitlist control)
Active, not recruiting
- Breast Cancer
- Psychological Distress
- Improvisational comedy classes
- Waitlist control
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Sep 19, 2022
The Benefit ofDeep Cleansing Gel in Management of Mild to
Completed
- Acne
- Deep Cleansing Gel
-
Rio de Janeiro, BrazilCIDP
Oct 14, 2022
Atopic Dermatitis Trial in Nice (tested formula with fiber, Control)
Recruiting
- Atopic Dermatitis
- tested formula with fiber
- Control
-
Nice, FranceCenter_05
Jul 18, 2022
Plaque Psoriasis Trial in Canada, United States (Vectical™ Ointment weekdays and Clobex® Spray weekends regimen, Clobex® Spray
Completed
- Plaque Psoriasis
- Vectical™ Ointment weekdays and Clobex® Spray weekends regimen
- Clobex® Spray morning and Vectical™ Ointment evening regimen
-
Los Angeles, California
- +5 more
Jul 28, 2022
Plaque Psoriasis Trial in Fountain Valley, Hialeah, Saint Joseph (Halobetasol Topical Lotion)
Terminated
- Plaque Psoriasis
- Halobetasol Topical Lotion
-
Fountain Valley, California
- +2 more
Dec 6, 2021
Pulmonary Vascular Disorder, Primary Pulmonary Hypertension, Systemic Sclerosis Trial in Dresden, Heidelberg (Riociguat Oral
Recruiting
- Pulmonary Vascular Disorder
- +3 more
- Riociguat Oral Tablet
- Placebo
-
Dresden, Germany
- +1 more
Jan 26, 2023
Melasma Trial in Los Angeles, Dallas (Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05%)
Completed
- Melasma
- Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05%
-
Los Angeles, California
- +1 more
Jul 28, 2022
Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast Trial in Scottsdale (LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT
Not yet recruiting
- Breast Cancer
- +2 more
- LS301-IT 0.025 mg/kg
- +3 more
-
Scottsdale, ArizonaIntegro Theranostics Research Site #1
Jun 2, 2023
MDD, Treatment Resistant Depression Trial in New York (AXS-05, Bupropion SR)
Enrolling by invitation
- Major Depressive Disorder
- Treatment Resistant Depression
- AXS-05
- Bupropion SR
-
New York, New YorkAxsome Research Site
Jul 20, 2021
Contraception Trial (Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets, norelgestrominum and
Completed
- Contraception
- Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets
- +2 more
- (no location specified)
Feb 2, 2022
Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw
Recruiting
- Advanced Ovarian Carcinoma
- +7 more
-
Bydgoszcz, Kujawsko-pomorskie, Poland
- +2 more
Mar 7, 2023
Treatment Resistant Depression, MDD Trial in United States (AXS-05 (dextromethorphan-bupropion))
Completed
- Treatment Resistant Depression
- Major Depressive Disorder
- AXS-05 (dextromethorphan-bupropion)
-
Little Rock, Arkansas
- +19 more
Jun 2, 2022
Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation, Psychomotor Trial in United States (AXS-05
Enrolling by invitation
- Agitation in Patients With Dementia of the Alzheimer's Type
- +2 more
- AXS-05 (dextromethorphan-bupropion)
-
Lafayette, California
- +26 more
Sep 29, 2022
Aflibercept in Routine Clinical Practice in Diabetic Macular
Completed
- Macular Edema
- Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
- Anti-VEGF therapies including: Eylea Aflibercept, VEGF Trap-Eye, BAY86-5321) and Ophthalmologicals / Antineovascularisation agents (S01LA05)
-
Multiple Locations, United Kingdom(unnamed)
Nov 1, 2021
Hypertension, Pulmonary Trial in Worldwide (Adempas (Riociguat, BAY63-2521))
Recruiting
- Hypertension, Pulmonary
- Adempas (Riociguat, BAY63-2521)
-
Besancon, France
- +15 more
Jan 31, 2023
Primary Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Heidelberg (Riociguat)
Recruiting
- Primary Pulmonary Arterial Hypertension
- Chronic Thromboembolic Pulmonary Hypertension
-
Heidelberg, GermanyCentre for Pulmonary Hypertension at the Thoraxklinik Heidelberg
Apr 14, 2022
Allergic Rhinitis Trial in Anshan (Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.).)
Not yet recruiting
- Allergic Rhinitis
- Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.).
-
Anshan, Guizhou, ChinaGuangjun Tang
Oct 5, 2022